IntegraGen's First-Half Revenues Climb 67 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – French biotech firm IntegraGen today announced that its first-half revenues increased 67 percent year over year driven by demand for its genomic services.

For the half-year, revenues rose to €2.5 million ($3.4 million) from €1.5 million a year ago, resulting in a 32 percent improvement in its net loss to €890,000, compared to €1.3 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.